drug · small molecule
REC-4881
Phase 2updated 3mo agoby $RXRX RECURSION PHARMACEUTICALS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
targets
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
all catalysts(0)
nothing on the calendar yet
Trials studying REC-4881
News(1)
- How well are AI-discovered drugs faring in the clinic?Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.biopharma_dive · 1mo ago
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that